“Secukinumab Sustains Individual Clinical Responses Over Time in Patients With Psoriatic Arthritis: 2-Year Results from a Phase 3 Trial”. SKIN The Journal of Cutaneous Medicine 2, no. S1 (February 23, 2018): S21. Accessed April 17, 2026. https://skin.dermsquared.com/skin/article/view/293.